Frequency and Antimicrobial Susceptibility Profile of Acinetobacter baumannii Isolated at a Tertiary Care Diagnostic Facility
DOI:
https://doi.org/10.51253/pafmj.v73i6.10108Keywords:
Acinetobacter bauamnnii, Antimicrobial susceptibility, Multi-drug resistanceAbstract
Objective: To evaluate the frequency and antimicrobial susceptibility pattern of Acinetobacter baumannii isolated at a tertiary care setting.
Study Design: Cross sectional study.
Place and Duration of Study: Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi Pakistan, from
July to Dec 2018.
Methodology: All the specimens submitted, which yielded the growth of Acinetobacter baumannii, were included in the study. Isolates were confirmed biochemically by using api 20NE. Antimicrobial susceptibility was done using standard procedures and as per CLSI's latest guidelines.
Results: Nine thousand nine hundred thirty-one specimens were submitted to the Microbiology Department AFIP for culture and antimicrobial susceptibility testing during the study period. Amongst these, 1633(16.5%) specimens yielded the growth of different pathogens. Of 1633 culture-positive isolates, 101(6.2%) were identified as Acinetobacter baumannii. Among these,34.6% of the isolates were recovered from respiratory specimens, while 29.7% from pus and pus swab specimens. Minocycline was the most sensitive antibiotic with 59.4% sensitivity, followed by Doxycycline, to which 48.5% of isolates were susceptible. Sensitivity to all other antimicrobials was 24% or less. In vitro, sensitivity to Carbapenems is very low.
Conclusion: Acinetobacter baumannii was isolated from 6.2% of specimens submitted for culture and susceptibility testing.
Minocycline was the most sensitive antibiotic, followed by Doxycycline. Sensitivity to most of the other antimicrobials was
24% or less. An alarming resistant pattern demands strict infection control practices and judicious use of antibiotics.
Downloads
Metrics
References
Tayabali AF, Nguyen KC, Shwed PS, Crosthwait J, Coleman
G, Seligy VL, et al. Comparison of the virulence potential
of Acinetobacter strains from clinical and environmental
sources. PLoS One2012; 7(5): e37024.
https://doi.org/10.1371%2Fjournal.pone.0037024
Tabassum S. Multidrug-resistant (MDR) Acinetobacter: a major
Nosocomial pathogen challenging physicians. Bangladesh J Med
Microbiol 2007; 01 (02): 65-68.
Hood MI,Mortensen BL,Moore JL,Zhang Y,Kehl-Fie TE,Sugitani
N, et al. Identification of an Acinetobacter baumannii zinc
acquisition system that facilitates resistance to calprotectinmediated zinc sequestration. PLoS Pathog 2012; 8(12): e1003068.
https://doi.org/10.1371/journal.ppat.1003068
Rice LB. Federal funding for the study of antimicrobial resistance
in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197(8):
–1081 https://doi.org/10.1086/533452
Zanetti G, Blanc DS, Federli I. Importation of Acinetobacter
baumannii into a burn unit: a recurrent outbreak of infection
associated with widespread environmental contamination.
Infect Control Hosp Epidemiol 2007; 28: 723-725.
https://doi.org/10.1086/517956
Peleg AY, Potoski BA, Rea RR. Acinetobacter baumannii
bloodstream infection while receiving tigecycline: a cautionary
report. J Antimicro Chemother 2007; 59: 128-131.
https://doi.org/10.1093/jac/dkl441
Saleem AF,Ahmed I,Mir F,Ali SR,Zaidi AK. Pan-resistant
Acinetobacter infection in neonates in Karachi, Pakistan. J Infect
Dev Ctries 2009; 4(1): 30-37.
Bonnin RA,Rotimi VO,Al Hubail M,Gasiorowski E, Al
Sweih N, Nordmann P, et al. Wide dissemination of GES-type
carbapenemases in Acinetobacter baumannii isolates in
Kuwait. Antimicrob Agents Chemother 2013; 57(1): 183-188.
https://doi.org/10.1128/aac.01384-12
Barbolla RE, Centron D, Maimone S, Rospide F, Salgueira C,
Altclas J, et al. Molecular epidemiology of Acinetobacter
baumannii spread in an adult intensive care unit under an
endemic setting. Am J Infect Control 2008; 36(6): 444-452.
https://doi.org/10.1016/j.ajic.2007.09.010
Mastoraki A, Douka E, Kriaras I, Stravopodis G, Saroglou G,
Geroulanos S, et al. Preventing strategy of multidrug-resistant
Acinetobacter baumanii susceptible only to colistin in cardiac
surgical intensive care units. Eur J Cardiothorac Surg 2008; 33(6):
–1090. https://doi.org/10.1016/j.ejcts.2008.02.012
Khan MA,Mahomed MF,Ashshi AM,Faiz A.Drug resistance
patterns of Acinetobacter baumannii in Makkah, Saudi Arabia.
Pak J Med Res 2012; 51(4): 127-131.
Xia Y, Lu C, Zhao J, Han G, Chen Y, Wang F, et al. A
bronchofiberoscopy-associated outbreak of multidrug-resistant
Acinetobacter baumannii in an intensive care unit in Beijing,
China. BMC Infect Dis 2012; 12: 335.
https://doi.org/10.1186/1471-2334-12-335
Merino M,Acosta J,Poza M,Sanz F,Beceiro A,Chaves F, et al.
OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter
species isolated during a nosocomial outbreak. Antimicrob
Agents Chemother 2010; 54(6): 2724-2727.
https://doi.org/10.1128/aac.01674-09
Mirza IA, Hussian A, Abbasi SA, Malik N, Satti L, Farwa U, et al.
Ambu bag as a source of Acinetobacter baumannii outbreak
in an intensive care unit. J Coll Physicians Surg Pak 2011; 21(3):
-178.
Muhammad F, Khan IU, Hussain A, Mirza IA, Ali S, Akbar N, et
al. Frequency and antimicrobial susceptibility pattern of
Acinetobacter species isolated from pus and pus swab
specimens. J Coll Physicians Surg Pak 2015; 25(5): 346-349.
Ntusi NB,Badri M,Khalfey H,Whitelaw A,Oliver S,Piercy J,
et al. ICU-associated Acinetobacter baumannii colonisation/
infection in a high HIV-prevalence resource-poor setting. PLoS
One 2012; 7(12): e52452.
https://doi.org/10.1371/journal.pone.0052452
Mushtaqa S, Javed I, Hassan M. Antibiotic sensitivity pattern of
Acinetobacter species isolated from clinical specimens in a
tertiary care hospital. Biomedica 2013; 29: 23-26.
A Gerardo, Midde M. Trends and factors associated with
antimicrobial resistance of Acinetobacter spp. Invasive isolates
from Europe: A country level analysis. J Glob Antimicrob Resist
: 14: 29-32. https://doi.org/10.1016/j.jgar.2018.05.024
Ramette A, Kronenberg A. Prevelence of carbapenem - resistant
Acinetobacter baumannii from 2005 to 2016 in Switzerland. BMC
Infect Dis 2018; 18(1): 159.
https://doi.org/10.1186/s12879-018-3061-5.
Purohit M,Mendiratta DK,Deotale VS,Madhan M,Manoharan A,
Narang P, et al. Detection of metallo-β-lactamases producing
Acinetobacter baumannii using microbiological assay, disc
synergy test and PCR. Indian J Med Microbiol 2012; 30(4): 456-
Downloads
Published
How to Cite
Issue
Section
